Haematology

Prof. Dr. Funda Ceran

Doctor and researcher Ankara Bilkent Şehir Hastanesi Ankara
Graft vs Host DiseaseLeukemia, Lymphocytic, Chronic, B-CellLeukemia, Promyelocytic, AcuteThrombosisMultiple Myeloma

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Graft vs Host Disease 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Leukemia, Lymphocytic, Chronic, B-Cell 3 publications
  • Leukemia, Promyelocytic, Acute 2 publications
  • Thrombosis 2 publications
  • Multiple Myeloma 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologysaglik.gov.trFrom source
  • InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
  • Area of workGraft vs Host DiseaseExtracted from 4 publications · Model version —From source
  • Publications104 publicationsORCID, OpenAlex, Europe PMCFrom source
  • ORCID0000-0003-3173-7614ORCIDFrom source
  • Last synchronised5 November 2026 07:22https://ankarasehir.saglik.gov.tr/TR-331019/hematoloji-klinigi-doktorlarimiz.html#funda-ceransaglik.gov.tr

Scientific work

Publications on Graft vs Host Disease

104 publications
  1. Salvage Autologous Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma: Long-Term Efficacy and Safety Outcomes from a Single-Center Real-World Cohort

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15187184 PMID 42795957 Open-access full textSource: ORCID

  2. Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center

    Hematology Reports, 2026

    DOI 10.3390/hematolrep18040049 PMID 42496448 Open-access full textSource: ORCID

  3. Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center

    Mediterranean Journal of Hematology and Infectious Diseases, 2026

    DOI 10.4084/mjhid.2026.044 PMID 42136896 Open-access full textSource: ORCID

  4. Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms

    International Journal of Endocrinology, 2026

    DOI 10.1155/ije/6041016 PMID 42147090 1 citation (Europe PMC) Open-access full textSource: ORCID

  5. Bidirectional Temporal Association Between Cytomegalovirus Reactivation and Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Real-World Cohort Study

    Viruses, 2026

    DOI 10.3390/v18080874 PMID 42655692 Open-access full textSource: ORCID

  6. Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G-CSF Treatment in Unrelated Donors

    Journal of Clinical Apheresis, 2026

    DOI 10.1002/jca.70089 PMID 41500932 Open-access full textSource: ORCID

  7. Steroid-associated hypofibrinogenemia: an overlooked risk in graft-versus-host disease management after allogeneic hematopoietic stem cell transplantation

    Blood Coagulation & Fibrinolysis, 2026

    DOI 10.1097/mbc.0000000000001460 PMID 42937018 Source: OpenAlex

  8. The Impact of Donor Hematological Parameters on Early Donor Complications: A Multicenter Donor Research Team Project

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2026

    DOI 10.1007/s12288-025-01966-4 PMID 41522542 Open-access full textSource: ORCID

  9. Tongue Uptake of 18F-FDG on PET/CT Mimicking Malignancy

    Clinical Nuclear Medicine, 2026

    DOI 10.1097/rlu.0000000000006401 PMID 41921937 Source: OpenAlex

  10. Ocular surface and corneal subbasal nerve plexus changes in ocular graft versus host disease patients treated with topical cyclosporine

    BMC ophthalmology, 2025

    DOI 10.1186/s12886-025-04366-4 PMID 41102752 1 citation (Europe PMC) Open-access full textSource: Europe PMC

View all 104 publications